| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 20, 2026 | Option exercise(M) | 25K | $11.90 | $298K | 49K |
| Jul 20, 2026 | Option exercise(M) | 80K | $11.17 | $894K | 129K |
| Jul 20, 2026 | Sell(S) | 70K | $29.96 | $2.1M | 59K |
| Jul 20, 2026 | Sell(S) | 32K | $31.05 | $990K | 27K |
| Jul 20, 2026 | Sell(S) | 3K | $31.71 | $92K | 24K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 20, 2026 | Option exercise(M) | 25K | — | $0 | 10K |
| Jul 20, 2026 | Option exercise(M) | 80K | — | $0 | 70K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-312387) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for NewAmsterdam Pharma Co N.V.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.